|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Xia C, Dong X, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China
and United States, 2022: Profiles, trends, and determinants. Chin
Med J (Engl.). 135:584–590. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brierley JD, Brierley J, Gospodarowicz MK
and Wittekind C: Ebscohost: TNM classification of malignant
tumours. Wiley Blackwell/John Wiley & Sons, Inc; Chichester,
West Sussex: 2017
|
|
4
|
Li J, Wang L, Wang X, Zhao Y, Liu D, Chen
C, Zhang HP and Pan J: Preliminary study of the internal margin of
the gross tumor volume in thoracic esophageal cancer. Cancer
Radiother. 16:595–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Liu Y, Che F, Luo Y, Huang W,
Heng X and Li B: Pattern of lymph node metastasis in thoracic
esophageal squamous cell carcinoma with poor differentiation. Mol
Clin Oncol. 8:760–766. 2018.PubMed/NCBI
|
|
6
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang HC and Tang KF: Clinical value of
integrated-signature miRNAs in esophageal cancer. Cancer Med.
6:1893–1903. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Li J, Tian L, Zhou C, Gao Y, Zhou
F, Shi S, Feng X, Sun N, Yao R, et al: MiRNA expression profile
reveals a prognostic signature for esophageal squamous cell
carcinoma. Cancer Lett. 350:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimada Y, Imamura M, Wagata T, Yamaguchi
N and Tobe T: Characterization of 21 newly established esophageal
cancer cell lines. Cancer. 69:277–284. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka H, Shibagaki I, Shimada Y, Wagata
T, Imamura M and Ishizaki K: Characterization of p53 gene mutations
in esophageal squamous cell carcinoma cell lines: Increased
frequency and different spectrum of mutations from primary tumors.
Int J Cancer. 65:372–376. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tanaka H, Shimada Y, Imamura M, Shibagaki
I and Ishizaki K: Multiple types of aberrations in the p16 (INK4a)
and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma
cell lines. Int J Cancer. 70:437–442. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou SM, Zhang F, Chen XB, Jun CM, Jing X,
Wei DX, Xia Y, Zhou YB, Xiao XQ, Jia RQ, et al: miR-100 suppresses
the proliferation and tumor growth of esophageal squamous cancer
cells via targeting CXCR7. Oncol Rep. 35:3453–3459. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Yang C, Tian X, Liang Y, Wang S,
Wang X, Shou Y, Li H, Xiao Q, Shu J, et al: Downregulation of
miR-100-5p in cancer-associated fibroblast-derived exosomes
facilitates lymphangiogenesis in esophageal squamous cell
carcinoma. Cancer Med. 12:14468–14483. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Zhang Z, Yu X, Li Q, Wang Q, Chang
A, Huang X, Han X, Song Y, Hu J, et al: SOX9/miR-203a axis drives
PI3K/AKT signaling to promote esophageal cancer progression. Cancer
Lett. 468:14–26. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou S, Yang B, Zhao Y, Xu S, Zhang H and
Li Z: Prognostic value of microRNA-100 in esophageal squamous cell
carcinoma. J Surg Res. 192:515–520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng Q, Chen L and Ni L: Association of
miR-203 expression with prognostic value in patients with
esophageal cancer: A systematic review and meta-analysis. J Invest
Surg. 36:22857802023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li L, Lou Z and Wang L: The role of FKBP5
in cancer aetiology and chemoresistance. Br J Cancer. 104:19–23.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hähle A, Merz S, Meyners C and Hausch F:
The many faces of FKBP51. Biomolecules. 9:352019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Febbo PG, Lowenberg M, Thorner AR, Brown
M, Loda M and Golub TR: Androgen mediated regulation and functional
implications of fkbp51 expression in prostate cancer. J Urol.
173:1772–1777. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang T, Ma C, Zhang Z, Zhang H and Hu H:
NF-kappaB signaling in inflammation and cancer. MedComm (2020).
2:618–653. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li B, Tsao SW, Li YY, Wang X, Ling MT,
Wong YC, He QY and Cheung AL: Id-1 promotes tumorigenicity and
metastasis of human esophageal cancer cells through activation of
PI3K/AKT signaling pathway. Int J Cancer. 125:2576–2585. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao Z, Yu F, Jia H, Ye Z and Yao S:
FK506-binding protein 5 promotes the progression of papillary
thyroid carcinoma. J Int Med Res. 49:30006052110083252021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mao S, Zhang D, Chen L, Tan J, Chu Y,
Huang S, Zhou W, Qin H, Xia Q, Zhao Y, et al: FKBP51 promotes
invasion and migration by increasing the autophagic degradation of
TIMP3 in clear cell renal cell carcinoma. Cell Death Dis.
12:8992021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Romano S, Xiao Y, Nakaya M, D'Angelillo A,
Chang M, Jin J, Hausch F, Masullo M, Feng X, Romano MF and Sun SC:
FKBP51 employs both scaffold and isomerase functions to promote
NF-kappaB activation in melanoma. Nucleic Acids Res. 43:6983–6993.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith E, Palethorpe HM, Ruszkiewicz AR,
Edwards S, Leach DA, Underwood TJ, Need EF and Drew PA: Androgen
receptor and androgen-responsive gene FKBP5 are independent
prognostic indicators for esophageal adenocarcinoma. Dig Dis Sci.
61:433–443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu T, Wang C and Xia Z: Overexpressed
FKBP5 mediates colorectal cancer progression and sensitivity to
FK506 treatment via the NF-kappaB signaling pathway. FEBS J.
291:3128–3146. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang RG, Zhang D, Zhao CH, Wang QL, Qu H
and He QS: FKBP10 functioned as a cancer-promoting factor mediates
cell proliferation, invasion, and migration via regulating PI3K
signaling pathway in stomach adenocarcinoma. Kaohsiung J Med Sci.
36:311–317. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen G, Li X, Zhou X, Li Y, Yu H, Peng X,
Bai X, Zhang C, Feng Z, Mei Y, et al: Extracellular vesicles
secreted from mesenchymal stem cells ameliorate renal ischemia
reperfusion injury by delivering miR-100-5p targeting FKBP5/AKT
axis. Sci Rep. 14:67202024. View Article : Google Scholar : PubMed/NCBI
|
